Immune cell therapy for advanced brain cancer
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a treatment using your own immune cells, called cytokine-induced killer cells, to fight advanced brain cancer (glioblastoma). It may help people whose cancer has returned after standard chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with grade 4 brain cancer (glioblastoma).
- Your cancer has come back after treatment, and you have had no more than 3 relapses or prior treatments.
- You have completed at least one full cycle of temozolomide chemotherapy without serious side effects or the cancer getting worse.
- You are at least 18 years old and able to care for yourself (Karnofsky score of 60 or more).
- You do not have diabetes, heart problems, or other serious uncontrolled illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving patients immune cells called cytokine-induced killer cells can help treat early-stage brain tumors (grade 1 or 2 gliomas). It may help keep the tumor from growing or coming back after standard treatments like radiation and chemotherapy.
This study is testing a new type of immune cell therapy (cytokine-induced killer cells) for people with glioblastoma, a type of brain cancer. The treatment may boost your immune system to fight the cancer.
This trial tests a type of immune cell therapy called cytokine-induced killer cells for people with advanced melanoma that has not responded to other treatments. It aims to see if these cells can help shrink or slow down the cancer.
This trial tests a new treatment for advanced brain cancers like glioma and meningioma. It combines your own immune cells (tumor-infiltrating lymphocytes or TILs) with an immunotherapy drug (pembrolizumab) to help your body fight the tumor. It's for people who have tried other treatments without success or have no standard options left.
This early-phase study tests an immune cell treatment (natural killer cells) plus temozolomide to treat melanoma that has spread to the brain. It’s for people whose brain spots are getting worse and who are not good candidates for certain types of brain radiation.
This early-stage study tests a treatment made from your tumor’s immune cells (TILs) to help shrink brain glioma. You may be considered if your glioma is back or has spread and standard options are no longer working (or don’t exist).
Hear when a new Cytokine-Induced Killer Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.